Roche Tina-Quant CRP Latex Test System Recalled for Low Results
Roche is recalling Tina-Quant CRP Latex High Sensitive test kits due to potential under-recovery of results, which may lead to incorrect cardiovascular risk assessments.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a risk of harm (delayed diagnosis of cardiovascular risk) where injury has not yet been reported, fitting the 'High' severity criteria.
Plain-English summary
Roche Diagnostics Operations, Inc. is recalling the Tina-Quant (Latex) HS Test System (C-Reactive Protein (Latex) High Sensitive), catalog number 11972855216, lot number 60445001. The recall involves 3,204 units that were distributed nationwide, including to facilities in Alabama, Arizona, California, Connecticut, Florida, Georgia, Kansas, Massachusetts, Missouri, New Jersey, New York, Pennsylvania, and Washington.
The recall was initiated because the test system shows an under-recovery of up to -25% at concentrations below 5 mg/L when used on the MODULAR ANALYTICS P module. This issue can lead to erroneously low C-reactive protein (CRP) results. Since CRP is used as a marker for the prediction of cardiovascular risk, an erroneous low result could lead to an incorrect cardiovascular risk assessment and a subsequent delay in further examination.
Healthcare facilities and laboratories should stop using the affected lot and contact Roche Diagnostics for instructions on returning the product or obtaining replacements. Consumers should consult their healthcare providers if they have received test results using this specific lot and are concerned about the accuracy of their cardiovascular risk assessment.
The recalled product
- Product
- Tina-Quant (Latex) HS Test System (C-Reactive Protein (Latex) High Sensitive) The Tina-Quant CRP (Latex) High Sensitive Immunoturbidimetric assay is for the in-vitro quantitative determination of C-reactive protein (CRP) in human serum and plasma on Roche automated clinical che
- Manufacturer
- Roche Diagnostics Operations, Inc.
- Affected units
- 3,204
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Catalog number: 11972855216
- lot number 60445001
Distribution
Related recalls
Same manufacturer · Roche Diagnostics Operations, Inc.
See all →- HighRoche cobas analyzer may repeat previous results for spline calibrated assays
FDA (Devices) · 2026-03-11
- HighThyroid receptor immunoassay recalled over variable results across instrument platforms
FDA (Devices) · 2026-01-14
- HighMedical Device Homocysteine Test Assay Recalled for Calibration Defects
FDA (Devices) · 2024-11-27
- HighRoche Creatine Kinase test reagents recalled for calibration errors
FDA (Devices) · 2024-10-02
- HighRoche Tina-quant D-Dimer Test System Recalled for Inaccurate Results
FDA (Devices) · 2023-11-29
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02